Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Resources to Help

    ... and support for fundraising and patient awareness. Leukemia Research Foundation ... assistance for Myelodysplastic Syndromes (MDS), Acute Myeloid Leaukemia (AML), Acute Lymphoblastic Leukemia (ALL), ... (800) 366-7741 Offers help to patients with chronic myelogenous leukemia. If you have access to insurance through COBRA, a ...

    Topic section last updated 09/28/2017 - 11:58am.

  2. Clone of Myelodysplastic Syndromes (MDS)

    ... others are more severe, and carry a high risk of becoming acute myelogenous leukemia (AML). The subtype you have, and the severity of your ...

    Page last updated 04/05/2016 - 3:56pm.

  3. MDS: Diagnosis

    ... about the CBC test. The Risk of Getting AML ( Acute Myelogenous Leukemia ) AML is a cancer of the white blood cells. It is ...

    Page last updated 01/20/2015 - 4:42pm.

  4. RIC Transplant Using Haplo Donors

    ... study is to estimate the incidence of graft rejection and acute GVHD. A secondary objective will be to estimate the incidence of the ... One of the following high-risk malignancies: Chronic Myelogenous Leukemia: Chronic myelogenous leukemia in chronic phase, resistant ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  5. Clinical Trials Report for December 2014

    ... Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) The goal of ...

    Page last updated 11/25/2014 - 3:33pm.

  6. Intra-Osseous Co-Transplant of UCB and hMSC

    ... must have one of the following malignancies: Acute myelogenous leukemia (AML): high-risk AML including: Antecedent ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  7. An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)

    ... chronic myelomonocytic leukemia and low-blast acute myelogenous leukemia . ...

    Clinical Trial last updated 04/28/2016 - 1:58pm.

  8. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... remission or with stable minimal residual disease Acute myelogenous leukemia (AML) in 1st or subsequent remission or in relapse ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.

  9. Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-3032b in Hematological Malignancies

    ... (RP2D) in subjects with refractory or relapsed Acute Myelogenous Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic ...

    Clinical Trial last updated 04/29/2016 - 1:50pm.

  10. Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

    ... range from zero to 30% but are typically short lived. Acute Lymphoblastic Leukemia (ALL) in first complete remission (CR1) that is NOT considered favorable-risk. Acute Myelogenous Leukemia (AML) in first complete remission (CR1) that is NOT ...

    Clinical Trial last updated 06/06/2016 - 10:54am.